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❑ Does the implementation of an 
opioid guideline, which includes a 
clinical decision support (CDS) tool 
in the electronic health record (EHR) 
for providers in a primary care 
urban clinic lead to decreased opioid 
prescribing and increased use of a 
CDS tool and opioid protocol 
elements?
❑ Improved documentation including 
opioid protocol elements
❑Opioids are currently the main cause of drug 
overdose deaths leading to more than 67.8% in 
2017 (Center for Disease Control [CDC], 2018)
❑1 in 5 adults received an opioid prescription in 
the last year and nearly 33% received an opioid 
prescription in the last two years (NORC at the 
University of Chicago, 2018)
❑19.1 million opioid prescriptions were written 
each month from 2012 to 2017 (Bohnert, Guy 
Jr., & Losby, 2018)
❑ Loyola does not currently have an opioid 
guideline for care of chronic opioid patients in 
the ambulatory setting
❑Quality Improvement Project
❑ Participants: Loyola Family Medicine Department providers (3 clinics: Maywood, Elmwood Park, 
Gottleib)
❑ Project: Established new opioid policy and created an EHR smart set consistent with newly created 
opioid policy during chronic pain office visits
❑ Education: Family Medicine providers educated via monthly department meeting and video 
distributed for providers not present during meeting
❑ Participants: Family medicine providers
❑ Sampling technique: Specific data collected from Electronic Health Record from chronic non-
cancer patients over 6 months
❑ Source of data: Electronic Health Records and chart audits; Longitudinal data from a cohort group 
❑ Budget:  Minimal; Printed material for ORT/COMM tools; Laminated copies of new Opioid Policy
❑ Timeline: 6 months
❑ Ethics and human subjects’ protection:  IRB exempt; EHR data without patient identifiers; Chart 
audits to only be done by DNP provider
❑ The newly created opioid policy and 
EHR smart set appears to have a 
positive influence and reduction on 
overall opioid prescribed, opioids 
over 90 MME and opioids 
prescribed concurrently with 
benzodiazepines
❑ Most likely there would have been a 
greater correlation if in person office 
visits continued
❑ The data provided is some of the 
first results observed when it comes 
to opioid prescribing and EHR smart 
sets with the combination of 
interventions included.  Therefore, it 
is difficult to compare with other 
studies.  
❑ Decrease opioid prescribing in a suburban 
family medicine department
❑Better patient outcomes
❑ Improved knowledge among Advance 
Practice Nurses (APN) and their physician 
colleagues
❑ Improved screening for opioid misuse with 






❑ Pre-implementation opioid prescribing 
rate was 3.25% and decreased to 2.4% 
during post implementation (Figure 1)
❑ Pre-implementation opioids over 90 
MME was 0.10% rate and decreased 
to 0.08% during post implementation 
(Figure 2)
❑ Finally, pre-implementation opioid and 
benzodiazepines prescribed 
concurrently occurred at a 0.23% rate 
and decreased to 0.20% rate during 
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